HUMAN METAPNEUMOVIRUS
Clinical trials for HUMAN METAPNEUMOVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN METAPNEUMOVIRUS trials appear
Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nasal spray vaccine aims to protect kids from two breathing viruses
⭐️ VACCINE ⭐️ CompletedThis study tested two experimental nasal spray vaccines in 24 children aged 2 to 5 years. The vaccines target two viruses that can cause breathing problems: human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3). The main goal was to see if the vaccines are safe and …
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:07 UTC
-
New combo vaccine targets two respiratory viruses in seniors
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against two respiratory viruses: RSV and hMPV. It involved 646 healthy adults aged 60 and older who received either the vaccine or a placebo. The goal was to see if the vaccine is safe and triggers a strong immune response, with…
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:01 UTC